
Sioxon-S 500mg/250mg Injection
Marketer
savoy Biotech
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Sioxon-S 500mg/250mg Injection
Combiflox-500 Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule; premature cessation can compromise its effectiveness. Complete the full course, even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Sufficient rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor treatment efficacy.
Uses of Sioxon-S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Sioxon-S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly discouraged.
Common Side effects of Sioxon-S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Sioxon-S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Sioxon-S 500mg/250mg Injection works:
The injectable formulation Sioxon-S (500mg Ceftriaxone/250mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Sulbactam, by counteracting bacterial resistance enzymes, augments Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Sioxon-S 500mg/250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Sioxon-S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal to no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Sioxon-S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Sioxon-S 500mg/250mg Injection can induce drowsiness, visual disturbances, and dizziness. Operation of a motor vehicle is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sioxon-S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Sioxon-S (500mg/250mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Sioxon-S (500mg/250mg) injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Sioxon-S 500mg/250mg Injection :
Omit a dose of Sioxon-S 500mg/250mg Injection? Seek your physician's advice.
Facts to Know About Sioxon-S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
